Walgreens Boots Alliance (WBA) Inc. has completed $12.8 billion in term loan facilities as part of the financing for its $17.2 billion deal to acquire Rite Aid Corp. WBA said Monday that the transactions include the placement of $5 billion of term loan facilities — split between two tranches of $2.
Longtime retail consultant/analyst Walter Loeb likes what he sees from CVS Health. In a Forbes article on Friday, Loeb described CVS as a compelling health and wellness destination, especially in the wake of its acquisition of Target Corp.
Tony Rogers reportedly has been appointed as chief marketing officer at Walmart. Published reports said Friday that Rogers, a 10-year company veteran who has been CMO of Walmart China for the past two years, succeeds Stephen Quinn, who is retiring.
Eli Lilly and Co. and Boehringer Ingelheim Pharmaceuticals Inc. have received approval for Basaglar long-acting insulin (insulin glargine injection, 100 units/ml) in the United States.
Merck has received approval from the Food and Drug Administration for an expanded age indication for Gardasil 9, its 9-valent human papillomavirus (HPV) vaccine.
Putting patients increasingly in control of their well-being and health care outcomes has truly come of age.
AstraZeneca plans to acquire the core respiratory business of Takeda Pharmaceutical Co. Ltd. for $575 million. Under the agreement, approximately 200 Takeda staff will transfer to AstraZeneca after the closing of the transaction, expected in the first quarter of 2016.
Rite Aid Corp. posted fiscal 2016 third-quarter adjusted earnings in line with Wall Street estimates and announced a special shareholders meeting to vote on its $17.2 billion deal to be acquired by Walgreens Boots Alliance Inc. Rite Aid said Thursday that for the third quarter ended Nov.
John Boehner, the former Speaker of the U.S. House of Representatives, will deliver the keynote address at the 2016 NACDS Annual Meeting. The National Association of Chain Drug Stores said that Boehner (R.
Peter Greenleaf, chief executive officer of Sucampo Pharmaceuticals Inc., has been appointed as chairman of the board. Sucampo said late Tuesday that Greenleaf, the company’s CEO and a board member since March 2014, is slated to take the reins as chairman on Jan. 1.
General Mills reports that it’s making headway in its effort sodium by 20% across 10 key U.S. retail product categories by the end of this year. The food company said Tuesday that it has met or exceeded its goal in seven of 10 categories, with reductions across the 10 categories ranging from 18%
Pharmacists in Rite Aid Corp.’s nearly 4,600 drug stores are now using the EQuIPP pharmacy performance measurement platform from Pharmacy Quality Solutions (PQS). Rite Aid said Wednesday that it’s the largest drug chain to enable EQuIPP access to all of its pharmacists.
CVS Health has completed its $1.9 billion acquisition of Target Corp.’s pharmacy and retail health clinic business. The companies said Wednesday that Target’s 1,672 pharmacies in 47 states will be branded as CVS/pharmacy and operated under a store-within-a-store format.
At its annual Analyst Day event here, CVS Health updated its earnings guidance for 2016 and reiterated its five-year targets.
one with outstanding growth potential for pharmacies that build strong differentiating capabilities. The Mexican pharmaceutical market grew 3% annually over the past few years to reach $14
Sanofi and Boehringer Ingelheim are in talks to swap their animal health and consumer health care businesses, respectively. The companies said Tuesday that the proposed transaction would involve an exchange of Sanofi’s Merial animal health business (“Merial”), valued at €11.4 billion ($12.
